Modern Mind Medicine

Psilobrain

Founded on the passion for science, wellness and mycology (the study of mushrooms). We pride ourselves on quality research, natural products and trusted brands.

Psilobrain

Built from industry leaders in pharma, regulatory affairs, public markets, retail and business development along with distinguished scientists and researchers. Our team has extensive experience in building global businesses. Psilobrain is a leader in the mushroom and psychedelic space with research backed products and applications along with top tier brands and worldwide distribution.

Psilobrain is a company that is helping people with research and scientist backed effective products and therapeutics for improved quality of life.

addressing the global need

Growing Global Industry

The global mushroom industry is seeing rapid growth on various frontiers; the nutraceutical and functional foods markets are seeing rapid expansion with a large driving factor being mushroom due to their various health and wellness benefits. Along with the health and wellness mushrooms psychedelic mushrooms are gaining popularity due to increased research in various therapeutic applications, along with increased research we are seeing overwhelmingly positive research in areas of mental health and rehabilitation.

$62 Billion

The expected edible mushroom market by 2023

Source

1 in 2

Canadian will be affected by a mental health issue by the age of 40

Source

80% Success

in nicotine addiction treatment study using psychedelic mushrooms

Source

Ancient Egyptians referred to mushrooms as the plant of immortality in hieroglyphics more than 4,600 years ago. Mushrooms were so revered in Egyptian society that commoners were forbidden from touching them. Mushrooms were a food exclusively for royalty.

OUR Products

Current and Future Products

Pharmaceuticals

Pure Psilocybin, Pure Psilocybin plus synergistic compounds

CPGs

Mushroom based nutrition products and consumables including delicious coffees and teas

Microdose

Psilocybin in small yet beneficial doses. (Future CPGs)

PSILOBRAIN

Our Pillars

Pharma

Bioscience

Combining industry specific experts and ground breaking psychedelic therapy to develop cutting edge and effective treatments for mental health issues impacting society at a global scale. Our focused research and clinical trials are a step in the process to develop pharmaceuticals and medicines based on psychoactive compounds for a variety of conditions or treatment efforts.

Psychedelics naturally promote serotonin levels in the brain and so may offer a viable alternative to conventional medicine when treating such conditions in the future. Psilocybin has potential therapeutic benefits based on clinical trials conducted to date on the following conditions: Anorexia nervosa, anxiety experienced by patients with a terminal diagnosis, social anxiety in patients with autism, depression: both MDD and TRD, PTSD, substance misuse, including alcohol, opioid and nicotine dependence, cluster headaches/migraines and symptoms of OCD.

Wellness

Nutraceuticals

The global functional food market is forecasted to reach USD 34.3 billion by 2024, growing at a CAGR of 8.04% during the forecast period (2019–2024), according to a report by Research and Markets. Reishi, Cordyceps, Lions Mane and several other mushrooms are used as natural health products in various forms such as capsules, tinctures, food products, coffees and teas.

Therapy and Therapeutics

Therapeutics

Depression, addiction, PTSD and other mental conditions are a diseases that have impacted the world, psychotherapy is promising possible soluton that comes withouts the side effects and addictive properties of current curative measure such as antidepressants and opioids.

100

100+ Years of Combined Pharmaceuticals and Bioscience Experience

75

75+ Years of Combined Retail and Global Distribution Experience

50

50+ Years of Combined Health and Wellness Market Experience

40

40+ Years of Comobined Marketing and CPG Experience

Applications

Psychedelic Therapy

“ It is fundamentally different than any other psychoactive drug. Because these experiences occur in most people, studies often look very similar to naturally-occurring experiences, and they appear to be biologically normal. That is, we seem to be wired to have such experiences.”

Roland Griffiths, Ph.D., Johns Hopkins University

Psilocybin

“ PTSD received Breakthrough Therapy Designation from the US FDA in 2017. Phase III clinical trials are underway in the US and Europe and licensing approval is expected as early as 2022. ”

Potential Therapeutic Applications

MDMA

“ There are anecdotal reports of mescaline being used for a wide range of purposes, including analgesia and headache relief, yet no evidence exists for these yet. ”

Potential Therapeutic Applications

Mescaline

“ DMT is a powerful yet short-lived hallucinogenic drug, which is a natural component of many living plants and animals, and is found in high concentrations of some plants used for psychedelic purposes, ”

Potential Therapeutic Applications

DMT

Get In Touch

EMAIL ADDRESS

Info@Psilobrain.com